In non-small cell lung cancer cell lines, EGF has been reported to activate TERT transcription by inducing direct binding of ETS2 and Myc/Max to the TERT promoter (Hsu et al., 2015). The gene discussed is TERT; the disease is non-small cell lung carcinoma.